2010, Number s1
<< Back Next >>
Cir Gen 2010; 32 (s1)
Conceptos actuales en el tratamiento de enfermedad hepática metastásica
Vilatobá CM
Language: Spanish
References: 6
Page: 9-10
PDF size: 29.20 Kb.
Text Extraction
REFERENCES
de Jong Mechteld C, Mayo SC, Pulitano C, Lanella S, Ribero D, et al. Repeat curative in ten liver surgery is safe and effective for recurrent colorectal liver metastasis: Results from an international multi-institutional analysis. J Gastrointest Surg 2009: (Epub ahead of print.)
Nash GM, Gimbel M, Shia J, Nathamson DR, Ndubuisi MI, Zeng ZS, Kemeny N, et al. KRAS mutation correlates with accelerated metastasic progression in patients with colorectal liver metastasis. Ann Surg Oncol 2009: (Epubaheadofprint).
Hermesen M, Postman C, Baak J, et al. Colorectal adenoma to carcinoma progression follows pathways of chromosomal instability. Gastroenterology 2002; 123: 1109-19.
Andrey HJ, Norman AR, Cunningham D, et al. Kristen ras mutations in patients with colorectal cancer: the “RASCAL II” study. Br J Cancer 2001; 85: 692-6.
Cao CQ, Yan TD, Liauw W, Morris DL. Comparison of optimally resected hepatectomy and peritonectomy patients with colorectal cancer metastasis. J Surg Oncol 2009; 100: 529-33.
de Jong CM, Pulitano C, Ribero D, et al. Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis. An international multi-institutional analysis of 1,669 patients. Ann Surg 2009; 250: 440-8.